Clinical Research Associate (CRA) – Site Selection
PSI CRO
Summary
Join PSI's dedicated Selection Visit Team and play a key role in identifying the investigative sites best positioned to successfully deliver our clinical trials.
Job description
As a Clinical Research Associate (CRA) – Site Selection, you will focus on the qualification and evaluation of prospective investigative sites prior to study activation. You'll conduct remote and onsite Site Selection Visits (SSVs), evaluate site capabilities and recruitment potential, identify operational risks, and provide evidence-based recommendations regarding site suitability.
Unlike a traditional CRA position, this role is primarily focused on site selection and study start-up rather than routine monitoring of activated sites.
Job Description
- Prepare for and conduct remote and onsite Site Selection Visits.
- Review protocols, feasibility questionnaires, investigator/site backgrounds, and study-specific requirements.
- Assess investigator qualifications, clinical research experience, availability, and oversight capabilities.
- Evaluate the site's patient population and realistic recruitment potential, including competing studies, referral networks, recruitment methods, and potential enrollment barriers.
- Critically assess site-provided enrollment projections and determine whether recruitment assumptions are realistic and appropriately supported.
- Evaluate site staffing, resources, facilities, equipment, pharmacy and laboratory capabilities, and protocol-specific requirements.
- Assess regulatory and operational readiness, including IRB processes, start-up timelines, essential documentation, source documentation practices, and investigator oversight.
- Identify potential risks or concerns that could impact successful study conduct.
- Provide clear, objective, and evidence-based recommendations regarding site suitability.
- Complete SSV reports and required follow-up accurately and within established timelines.
- Collaborate closely with Study Start-Up, Clinical Operations, Project Management, and investigative sites.
- Independently manage SSV activities across approximately 4–5 studies simultaneously.
Qualifications
- Minimum 2 years of independent CRA monitoring experience.
- Experience conducting Site Selection Visits is strongly preferred.
- Experience supporting interventional clinical trials, ideally Phase I–III studies.
- Oncology and/or gastrointestinal (GI) clinical trial experience is a plus but not required.
- Strong understanding of site operations, investigator responsibilities, patient recruitment, and clinical trial conduct.
- Strong critical-thinking skills with the ability to evaluate information objectively and identify potential site-level risks.
- Ability to confidently challenge unsupported assumptions and make well-reasoned site recommendations.
- Strong communication, organization, and documentation skills.
- Ability to work independently while managing multiple studies and priorities.
- Ability and willingness to travel nationally approximately 80%, including air travel and overnight stays.
Requirements
- Minimum 2 years of independent CRA monitoring experience
- Experience conducting Site Selection Visits strongly preferred
- Experience supporting interventional clinical trials, ideally Phase I–III studies
- Oncology and/or gastrointestinal (GI) clinical trial experience is a plus but not required
- Strong understanding of site operations, investigator responsibilities, patient recruitment, and clinical trial conduct
- Strong critical-thinking skills with the ability to evaluate information objectively and identify potential site-level risks
- Ability to confidently challenge unsupported assumptions and make well-reasoned site recommendations
- Strong communication, organization, and documentation skills
- Ability to work independently while managing multiple studies and priorities
- Ability and willingness to travel nationally approximately 80%, including air travel and overnight stays
Company overview
PSI CRO is a leading global contract research organization (CRO) specializing in full-service clinical development for pharmaceutical and biotechnology companies. Founded in 1995, PSI has established itself as a prominent player in the clinical research industry with operations spanning across North America, Europe, Asia, and Australia. The company focuses on delivering high-quality clinical trial services with particular expertise in oncology, central nervous system disorders, infectious diseases, and rare conditions. PSI's operational model emphasizes therapeutic expertise, operational excellence, and a patient-centric approach to clinical research. With a team of experienced professionals, the company manages all phases of clinical development from study design and protocol development to regulatory submissions and post-marketing studies. PSI is known for its efficient study execution, robust quality management systems, and commitment to accelerating drug development timelines while maintaining rigorous scientific standards.